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Background: Stenodactylin is a highly toxic plant lectin puriﬁed from the caudex of Adenia stenodactyla, with
molecular structure, intracellular routing and enzyme activity similar to those of ricin, a well-known type 2
ribosome-inactivating protein. However, in contrast with ricin, stenodactylin is retrogradely transported not
only in peripheral nerves but also in the central nervous system.
Purpose: Stenodactylin properties make it a potential candidate for application in neurobiology and in exper-
imental therapies against cancer. Thus, it is necessary to better clarify the toxic activity of this compound.
Study design: We investigated the mechanism of stenodactylin-induced cell death in the neuroblastoma-
derived cell line, NB100, evaluating the implications of different death pathways and the involvement of
oxidative stress.
Methods: Stenodactylin cytotoxicity was determined by evaluating protein synthesis and other viability pa-
rameters. Cell death pathways and oxidative stress were analysed through ﬂow cytometry and microscopy.
Inhibitors of apoptosis, oxidative stress and necroptosis were tested to evaluate their protective effect against
stenodactylin cytotoxicity.
Results: Stenodactylin eﬃciently blocked protein synthesis and reduced the viability of neuroblastoma cells
at an extremely low concentration and over a short time (1 pM, 24 h). Stenodactylin induced the strong and
rapid activation of apoptosis and the production of free radicals. Here, for the ﬁrst time, a complete and long
lasting protection from the lethal effect induced by a toxic type 2 ribosome-inactivating protein has been
obtained by combining the caspase inhibitor Z-VAD-fmk, to either the hydrogen peroxide scavenger catalase
or the necroptotic inhibitor necrostatin-1.
Conclusion: In respect to stenodactylin cytotoxicity, our results: (i) conﬁrm the high toxicity to nervous cells,
(ii) indicate that multiple cell death pathways can be induced, (iii) show that apoptosis is the main death
pathway, (iv) demonstrate the involvement of necroptosis and (v) oxidative stress.
© 2015 The Authors. Published by Elsevier GmbH.
This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Abbreviations: BHA, butylated hydroxyanisole; CAT, catalase; DAPI, 4´,6-diamidino-
2-phenylindole; EC50 and ET50, effective concentration and time required to reduce
cell viability by 50%; ER, endoplasmic reticulum; IC50 and IT50, concentration and
time required to inhibit cell protein synthesis by 50%; ψm, transmembrane elec-
trical potential gradient; NAC, N-acetyl-L-cysteine; NaPyr, sodium pyruvate; Nec-1,
necrostatin-1; PBS, phosphate buffered saline; PI, propidium iodide; ROS, reactive oxy-
gen species; RPMI-1640, Roswell Park Memorial Institute medium 1640; SOD, super-
oxide dismutase; UPR, unfolded protein response; Z-VAD-fmk, carbobenzoxy-valyl-
alanyl-aspartyl-[O-methyl]- ﬂuoromethylketone.
∗ Corresponding author. Tel.: +39 051 2094700; fax: +39 051 2094746.
E-mail address: letizia.polito@unibo.it (L. Polito).
I
A
t
3
e
t
w
o
t
http://dx.doi.org/10.1016/j.phymed.2015.11.006
0944-7113/© 2015 The Authors. Published by Elsevier GmbH. This is an open access article untroduction
Stenodactylin is a highly toxic lectin puriﬁed from the caudex of
denia stenodactyla (Pelosi et al. 2005; Stirpe et al. 2007) belonging
o ribosome-inactivating proteins, a family of RNA N-glycosylases (EC
.2.2.22) widely expressed throughout the plant kingdom (Di Maro
t al. 2014). These plant toxins speciﬁcally cleave adenine from
he highly conserved sarcin/ricin loop on eukaryotic 28S rRNA
ith different potencies. Some of these toxins also deadenylate
ther nucleotide substrates, such as mRNA, tRNA, DNA and poly(A);
hus, it was proposed to classify them as polynucleotide:adenosinender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tlycosylases (Barbieri et al. 2000; Bolognesi et al. 2002). Ribosome-
nactivating proteins are structurally divided into two main groups:
ype 1 proteins comprise a single A-chain with enzymatic activity,
nd type 2 proteins comprise an A-chain linked to a lectin B-chain
hrough a disulphide bond, the most well-known type 2 protein
eing ricin (Stirpe and Battelli 2006). The presence of the B-chain
an facilitate the binding to the cell surface and mediate the entry
f the whole toxin into the cell. Inside the cell, the A and B moi-
ties are separated, and the active A-chain, freed from steric hin-
rance, exerts enzymatic activity. Although several type 2 ribosome-
nactivating proteins are very toxic, a number of similar non-toxic
roteins have been identiﬁed in some plant species (Battelli 2004),
ost of them belonging to the Sambucus genus (Ferreras et al. 2011).
tenodactylin shares the same intracellular routing observed for
icin; the high cytotoxicity of this compound has been associated
ith a high-aﬃnity binding to receptors, great uptake and low pro-
eolysis, thereby facilitating the re-uptake of non-degraded lectin
Battelli et al. 2010).
Although the mechanisms involved in the cytotoxicity of plant
oxins are quite controversial, there are evidences that protein syn-
hesis inhibition is not the main event (Das et al. 2012).
By damaging rRNA, ribosome-inactivating proteins are capable of
ctivating the ribotoxic stress response with the following induction
f mitogen-activated protein kinases (MAPKs) and programmed cell
eath. Moreover, these toxins have been suggested to induce the en-
oplasmic reticulum (ER) stress and the consequent unfolded pro-
ein response (UPR). This response is triggered by the accumulation of
runcated and misfolded proteins in the ER lumen of intoxicated cells
Horrix et al. 2011). Using different cellular models, previous stud-
es demonstrated that oxidative stress mediates cell death induced
y several plant toxins, among which is abrin (Bora et al. 2010; Shih
t al. 2001), Viscum album L. coloratum agglutinin (Kim et al. 2004),
icin (Sehgal et al. 2011) and trichosanthin (Zhang et al. 2001). It has
lso been suggested that saporin cytotoxicity could depend on direct
NA damage, because of: (i) thewell-known deadenylating activity of
ibosome-inactivating proteins on puriﬁed DNA (Barbieri et al. 1997;
attelli et al. 1997), (ii) the nuclear localisation of saporin and (iii)
he contemporary presence of DNA gaps resulting from abasic sites
n HeLa intoxicated cells (Bolognesi et al. 2012).
The ability of ribosome-inactivating proteins, either type 1 or
ype 2, to induce cell death through apoptosis has been extensively
emonstrated using different in vitro and in vivo models (reviewed
y Battelli 2004; Das et al. 2012). The exposure of cells to some
lant toxins reduces the mitochondrial transmembrane electrical po-
ential gradient (ψm), resulting in the activation of caspases and
ubsequent apoptosis (Kim et al. 2004; Narayanan et al. 2004). The
ype 1 ribosome-inactivating protein saporin was reported to in-
uce apoptotic cell death through mitochondrial cascade, indepen-
ently of translation inhibition (Sikriwal et al. 2008). Beside the in-
rinsic pathway, also the extrinsic pathway of caspase activation has
een demonstrated to be eﬃciently induced by type 2 ribosome-
nactivating proteins (Polito et al. 2009).
In addition to apoptosis, increasing evidence suggests that these
lant toxins elicit alternative molecular mechanisms that trigger dif-
erent cell death programmes. Both caspase-dependent and indepen-
ent cell death pathways have been described for several ribosome-
nactivating proteins (Polito et al. 2009; Bora et al. 2010).
Following caspase inhibition, plant toxins kill cells through alter-
ative cell death pathways that possess the morphological features
f necrosis (Bora et al. 2010). Accumulating evidence has revealed
hat necrosis also functions as an alternative programmed mode of
ell death, triggered through the same signals that induce apoptosis.
his “programmed necrosis” has been deﬁned as necroptosis, and this
ondition becomes evident when normal apoptosis has been blocked,
or example, using caspase inhibitors. Necroptosis has been recently
ndicated as an independent pathway that can be particularly rele-ant in some cell types, including neurons (Degterev et al. 2005; You
t al. 2008).
Plant toxins have received much attention concerning their appli-
ation in medicine. After linking to appropriate carriers, particularly
onoclonal antibodies (immunotoxins), these proteins have been
sed in experimental therapies against cancer, demonstrating partic-
larly promising eﬃcacy in haematological malignancies (Bolognesi
nd Polito 2004; Polito et al. 2011, 2013). Plant toxin-containing im-
unotoxins have also been used in neurobiology experiments (Wiley
008).
All tested toxic lectins are retrogradely transported in peripheral
erves, whereas only Adenia toxins are also retrogradely transported
n the central nervous system (Monti et al. 2007; Wiley and Kline
000). This “suicide transport” facilitates the transport of toxins to
he cell body for neuron killing. Thus, Adenia toxins could be used for
argeted-lesioning experiments to induce the death of selected neu-
onal elements or populations.
Despite ribosome-inactivating proteins are known for a very long
ime, the exact mechanism of their toxicity remains unsolved and de-
erves to be clariﬁed mainly because of their pharmacological use
n medicine. Here, we investigated the mechanism of stenodactylin-
nduced cell death in a neuroblastoma-derived cell line, evaluating
he implications of different death pathways and the involvement of
xidative stress.
aterials and methods
eagents
Stenodactylin was puriﬁed from the caudex of Adenia stenodactyla
s previously described (Stirpe et al. 2007). Purity was > 99%.
The pan-caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl-
O-methyl]- ﬂuoromethylketone (Z-VAD-fmk, hereinafter indi-
ated as Z-VAD) was purchased from Vinci-Biochem (Florence,
taly); necroptosis inhibitor necrostatin-1 (Nec-1), and the reac-
ive oxygen species (ROS) scavengers, butylated hydroxyanisole
BHA), catalase (CAT), N-acetyl-L-cysteine (NAC), sodium pyruvate
NaPyr), superoxide dismutase (SOD) and (±)-6-hydroxy-2,5,7,8-
etramethylchromane-2-carboxylic acid (Trolox) were purchased
rom Sigma (Sigma-Aldrich, St. Louis, MO, USA). All other reagents
ere purchased from Sigma-Aldrich and were of analytical grade.
ell culture
The human neuroblastoma-derived NB100 cell line (Bolognesi
t al. 2013) was maintained at the logarithmic phase of growth in
oswell Park Memorial Institute medium 1640 (RPMI-1640), supple-
ented with 10% (v/v) heat-inactivated foetal bovine serum, 2 mM L-
lutamine, 100 U/ml penicillin G and 100 μg/ml streptomycin (here-
fter referred to as complete medium) at 37 °C in a humidiﬁed atmo-
phere containing 5% CO2 in a HeraCell Haraeus incubator (Hanau,
ermany).
ell protein synthesis
NB100 cells (2 × 104/well) were seeded onto 24-well plates in
50μl of complete medium in the absence (control cultures) or pres-
nce of stenodactylin. After 48 h, cell protein synthesis was evaluated
s previously described (Battelli et al. 2010). The IC50 and IT50 (sten-
dactylin concentration and time required to inhibit cell protein syn-
hesis by 50%) were calculated using linear regression analysis.
ell viability
Cell viability was evaluated as previously described (Battelli et al.
010). The EC50 and ET50 (stenodactylin effective concentration and
ime required to reduce cell viability by 50%) were calculated using
34 L. Polito et al. / Phytomedicine 23 (2016) 32–41
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tlinear regression analysis. Stenodactylin toxicity was also evaluated
using NB100 cells pretreated with 100 μM Z-VAD, 100 μM Nec-1,
30 μM BHA, 10 U/ml CAT, 30 μM NAC, 1 mM NaPyr, 100 U/ml SOD
or 30 μM Trolox (the highest concentrations resulted not toxic for
NB100 cells in preliminary tests). The reagents were added to cells 3 h
before stenodactylin administration. The protective effect of Z-VAD,
CAT and Nec-1 was also evaluated in two-by-two combination exper-
iments, using the above reported concentrations and preincubation
times. Subsequently, the cells were treated for 2 h with 10−12 M sten-
odactylin and, after washing with 5mM sodium phosphate buffer, pH
7.5, containing 0.14 M NaCl (PBS), further incubated for the indicated
times in complete medium.
Cell and nuclear morphology
The morphological analysis of the treated cells was conducted
through phase contrast microscopy directly in 96-well plates using
a digital camera from Motic Microscopes, (Xiamen, Fujian, China).
The nuclear morphology was captured after seeding NB100 cells
(2 × 104/500 μl of complete medium) onto 10-mm coverslips in
24-well plates at 48 h prior to treatment. Subsequently, the cells
were ﬁxed with 2% p-formaldehyde for 30 min, washed with PBS,
incubated with 7 μl DAPI (4´,6-diamidino-2-phenylindole)/antifade
and visualized using a Nikon Eclipse E600W ﬂuorescencemicroscope
(Nikon, Melville, NY, USA).
Analysis of the mitochondrial transmembrane electrical potential
gradient
Themitochondrialψmwas examined after staining NB100 cells
with the cationic, lipophilic dye JC-1 contained in the Mitochondria
Staining Kit (Sigma-Aldrich), which upon aggregation, exhibits a ﬂu-
orescence emission shift from 530 nm (green monomer) to 590 nm
(red “J-aggregates”=healthy cells). The cells (2 × 104/500 μl) were
directly seeded onto coverslips in 35-mm dishes at 48 h prior to
treatment with stenodactylin for 24 h, and subsequently stained with
500 μl of JC-1 dye (1:100 in RPMI) and incubated at room tempera-
ture in the dark for 10 min. The cells were washed three times and
observed under a ﬂuorescence microscope.
AnnexinV/Propidium iodide (PI) analysis
Apoptotic and necrotic changes were detected through ﬂow cy-
tometry and ﬂuorescence microscopy using the AnnexinV-EGFP
Apoptosis Kit (BioVision, Inc., Milpitas, CA, USA).
Flow cytometry experiments: The cells (2 × 105/3 ml) were
seeded in 25-cm2 ﬂasks and after 24 h treated with stenodactylin. Af-
ter treatment, the cells were centrifuged at 400×g for 5 min, washed
in 2 ml fresh medium, centrifuged again and stained according to the
manufacturer’s instructions. Within 30 min, the cells were analysed
through ﬂow cytometry on a FACSAria BD Analyser using FACSDiva
software (Becton, Dickinson and Company, Franklin Lakes, NJ, USA).
Fluorescence microscopy experiments: The cells (1.5 × 104/
500 μl) were directly seeded onto coverslips in 35-mm dishes at
48 h prior to the experiments. After the indicated time, 198 μl
of binding buffer, 1 μl of AnnexinV-EGFP and 1 μl of PI were
added. Following incubation at room temperature for 10 min in the
dark, the coverslips were inverted onto slides, and apoptotic cells
(AnnexinV+/PI−), necrotic cells (AnnexinV−/PI+) and late stage apop-
totic cells (AnnexinV+/PI+) were observed under a ﬂuorescence mi-
croscope, as described above. Merged images were obtained using
Image J 1.42q software.
Caspase 3/7 activity
The caspase 3/7 activity was assessed using the luminescent
Caspase-Glo® 3/7 assay (Promega Corporation, Madison, WI, USA).he cells (4 × 103/well) were seeded onto 96-well microtiter plates
n 100μl of complete medium. After 24 h, the cells were treated with
0−12 M stenodactylin for the indicated times. Caspase 3/7 activation
as evaluated as already described (Bolognesi et al. 2013). For ex-
eriments using inhibitors or scavengers, stenodactylin was added
t 3 h after treatment with the inhibitors and the cells were further
ncubated for 2 h. Fresh medium containing the scavengers and the
nhibitors was changed every 24 h.
ssessment of oxidative stress
The generation of ROS was detected through ﬂow cytometry and
uorescence microscopy using the Superoxide Detection Kit (Enzo
ife Sciences, Farmingdale, NY, USA).
Flow cytometry experiments: The cells (4 × 105/3 ml) were
eeded in 25-cm2 ﬂasks and treated with stenodactylin 10−12 M for
h. After trypsinization, the cells were washed, and the pellet was
e-suspended in 500 μl of Superoxide Detection Mix, according to
he manufacturer’s instructions. Within 30 min, the cells were anal-
sed through ﬂow cytometry, in PE-channel, using the FACSAria BD
nalyser.
Fluorescence microscopy experiments: The cells (1.5 × 104/
00 μl) were seeded directly onto coverslips in 35-mm dishes 48 h
rior to stenodactylin (10−12 M) treatment. After 8 h, the medium
as removed and 600 μl of Superoxide Detection Mix was added.
ollowing incubation at 37 °C for 1 h in the dark, the cells were ob-
erved under a ﬂuorescence microscope, as described above.
tatistical analysis
Statistical analyses were conducted using XLSTAT-Pro software,
ersion 6.1.9 (Addinsoft 2003). The results are presented as themeans
S.D. of three different experiments. The data were analysed using
NOVA/Bonferroni test. The Dunnett’s test was used in addiction to
NOVA, when necessary.
esults
tenodactylin is toxic to NB100 cells at a very low concentration
The toxicity of stenodactylin towards NB100 cells was determined
y evaluating both protein synthesis inhibition and viability reduc-
ion to assess the correlation between translation impairment and
ell viability (Fig. 1).
Dose-response curves, shown in Fig. 1A, demonstrated that pro-
ein synthesis and cell viability proceed in a parallel manner. After
8 h, stenodactylin strongly reduced both protein synthesis and via-
ility, with an IC50 of 4 × 10−14 M and an EC50 of 2.5 × 10−14 M. Both
rotein synthesis and viability were completely inhibited at a con-
entration of 10−12 M, and this concentration was used for all further
xperiments. In time-course experiments, stenodactylin signiﬁcantly
educed protein synthesis after 6 h (p < 0.01), and an almost total
rrest was observed after 16 h. However, stenodactylin did not sig-
iﬁcantly affect cell viability until 12 h, after this time cell viability
apidly sloped and was completely abolished after 24 h (Fig. 1B).
tenodactylin induces a strong and rapid activation of apoptosis
We examined the presence of cellular and nuclear morphologi-
al changes in NB100 cells treated for 24 h with stenodactylin us-
ng phase contrast microscopy and ﬂuorescence microscopy, respec-
ively. The visual inspection of stenodactylin treated NB100 cells with
hase contrast microscopy showed morphological features charac-
eristic of apoptosis, including cell shrinkage, cell membrane bleb-
ing, and cytoplasmic condensation (Fig. 2A). Nuclear examination
hrough ﬂuorescence microscopy after DAPI staining showed the
L. Polito et al. / Phytomedicine 23 (2016) 32–41 35
Fig. 1. Effect of stenodactylin on protein synthesis and viability in NB100 cells. Pro-
tein synthesis (◦) and cell viability () were evaluated at 48 h after exposure to the
indicated concentrations of stenodactylin (A) or in time-course experiments with cells
exposed to 10−12 M stenodactylin (B). The mean results ± S.D. are reported, represent-
ing the percentage of control values obtained from cultures grown in the absence of
stenodactylin. IC50 and IT50 are the concentration and the time required to inhibit 50%
of protein synthesis. EC50 and ET50 are the concentration and the time required to re-
duce cell viability by 50%. Data were analysed by ANOVA/Bonferroni test, followed by
a comparison with Dunnett’s test (conﬁdence range 95%; ∗∗ p < 0.01 versus untreated
cells, ∗∗∗∗ p ≤ 0.0001 versus untreated cells).
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Fig. 2. Activation of apoptosis through stenodactylin in NB100 cells. Cells were cul-
tured in the absence or in the presence of 10−12 M stenodactylin for 24 h. Morphol-
ogy of cells was assessed using phase contrast microscopy (600×) (A) and ﬂuores-
cence microscopy after incubation with DAPI (600×) (B). Mitochondrial transmem-
brane potential of cells was followed by staining with JC-1 and analysis through ﬂuo-
rescence microscopy (600×) (C). Apoptosis/necrosis was evaluated after AnnexinV/PI
staining and ﬂow cytometry analysis. Representative plots of AnnexinV (FITC chan-
nel)/PI (PE channel) staining of NB100 cells are shown (D). Caspase 3/7 activation was
determined in cells treated with 10−12 M stenodactylin for different times (2–16 h).
The mean results ± S.D. are reported, representing the percentage of control values
obtained from cultures grown in the absence of stenodactylin. Data were analysed
by ANOVA/Bonferroni test, followed by a comparison with Dunnett’s test (conﬁdence
range 95%; ∗ p < 0.05 versus untreated cells, ∗∗∗∗ p ≤ 0.0001 versus untreated cells) (E).resence of chromatin condensation and nuclear blebs (Fig. 2B). Al-
erations of the ψm were detected through ﬂuorescence in cells
xposed to stenodactylin for 24 h after staining with JC-1 (Fig. 2C). In
ontrol cells, JC-1 formed characteristic J-aggregates in mitochondria,
ielding red ﬂuorescence, whereas in stenodactylin-treated cells, JC-
remained in the monomeric form, producing green ﬂuorescence,
ndicating low ψm. These results conﬁrm that cells undergo apop-
osis after stenodactylin intoxication and that mitochondria are in-
olved.
Double staining with AnnexinV/PI through ﬂow cytometry
emonstrated that most NB100 cells treated with stenodactylin for
4 h showed the typical features of late stage apoptosis (Fig. 2D).
To demonstrate the involvement of caspase-dependent apopto-
is, caspase 3/7 activation was measured in cells exposed to sten-
dactylin for different incubation times from 2 h to 16 h (Fig. 2E). This
xperiment showed the strong activation of effector caspases, which
ecame signiﬁcant after 4 h (p < 0.05) and with a plateau observed
fter 8 h and a 770% activation value compared with untreated cells.
eactive oxygen species scavengers protect cells from stenodactylin
oxicity
To verify the involvement of ROS after treatment with sten-
dactylin the level of superoxide anion was measured through both
uorescencemicroscopy and cytoﬂuorometry. The presence of super-
xidewas demonstrated in NB100 cells treatedwith stenodactylin for
36 L. Polito et al. / Phytomedicine 23 (2016) 32–41
Fig. 3. Involvement of oxidative stress induced through stenodactylin in NB100 cells. Superoxide production in NB100 cells treated with stenodactylin (10−12 M) for 8 h was
assessed using ﬂuorescence microscopy (600×) (A) and cytoﬂuorometry (B). Cells were treated for 2 h with stenodactylin alone (●) or preceded by a 3-h preincubation with the
scavengers (30μMBHA, 10 U/ml CAT, 30μMNAC, 1 mMNaPyr, 100 U/ml SOD or 30μMTrolox) (◦), and viability was measured at the indicated times (C). The results are presented
as the means ± S.D. of three independent experiments performed in triplicate, representing the percentage of control values obtained from cultures grown in the absence of the
lectin. Data were analysed by ANOVA/Bonferroni test (conﬁdence range 95%; ∗∗∗∗ p ≤ 0.0001 versus cells treated with stenodactylin alone).
(
2
r
t
t
t
C
n
s8 h through both ﬂuorescence microscopy (Fig. 3A) and cytoﬂuorom-
etry (Fig. 3B), revealing that 11.3% of cells were positive to superoxide,
in contrast with the 1.2% of positive cells reported for untreated cells.
To further analyse the contribution of ROS in cell death pathways
induced by stenodactylin, the protective role of several ROS scav-
engers, i.e., BHA, CAT, NAC, NaPyr, SOD and Trolox in stenodactylin-
intoxicated cells was investigated in time-response experiments (24–
96 h) (Fig. 3C). No protection from stenodactylin induced cell death
was observed pretreating cells with SOD. All the other scavengers
gave a strong cell protection. The protective effect was higher at 24 h75–100% of cell survival) and decreased over time, though at 96 h
5–50% of cells are still alive. The highest level of protection was
eported for CAT, leading to the survival of approximately 100% of
reated cells after 24 h, and about 50% after 48 h, this effect wasmain-
ained at all the other tested times (up to 96 h).
To demonstrate that the protection exerted through CAT reﬂects
he enzymatic activity of thismolecule, the cells were pretreatedwith
AT previously inactivated with heat for 30min at 65 °C. As expected,
o protective effect towards stenodactylin was observed (data not
hown).
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otenodactylin toxicity is considerably reduced through the inhibition of
he apoptotic or necroptotic pathway
To determine the role of caspase-dependent programmed cell
eath, the pan-caspase inhibitor Z-VAD, which irreversibly binds to
he catalytic site of caspases, was used to selectively inhibit the
poptotic pathway. NB100 cells were pretreated and maintained in
00 μM Z-VAD, and the cell viability was determined at different
ime points (24, 48, 72 and 96 h). As shown in Fig. 4A, Z-VAD com-
letely blocked caspase activation at all the considered time points.
uch caspase inhibition reduced almost to zero the cytotoxicity of
tenodactylin after 24 h from intoxication. However, the protective ef-
ect of the pan-caspase inhibitor decreased over time, leading to 10%
iability after 96 h. These results not only demonstrated the preva-
ence of apoptosis in the ﬁrst 24 h but also indicated the involvement
f caspase-independent cell death pathways. Moreover, in the pres-
nce of the necroptosis inhibitor Nec-1, stenodactylin-induced cell
eath was strongly reduced at 24 h, with a viability of approximately
0%. Subsequently at 48, 72 and 96 h, cell viability decreased to ap-
roximately 25%. Therefore, Nec-1 was slightly more effective than
-VAD in protecting cells from long-term intoxication (Fig. 4B).
After 72–96 h, cells pretreated with Z-VAD appeared small, with
ound or oval shape and pyknotic nuclei. In contrast, cells pretreated
ith Nec-1 showed heterogeneous cellular and nuclear morphologi-
al characteristics, with the presence of both shrunken and rounded
ells (Fig. 4C)
The cells were subjected to AnnexinV/PI double staining after
reatment with stenodactylin in the presence or absence of the two
nhibitors to conﬁrm the death pathway(s) primarily involved after
8 h of treatment (Fig. 4D). Typical double ﬂuorescence, compatible
ith late apoptosis, was observed in stenodactylin-intoxicated cells.
owever, only red ﬂuorescence was observed in cells pretreated with
-VAD, indicating the membrane damage and PI staining typical of
on-apoptotic death. In contrast, double ﬂuorescence was observed
or cells pretreated with Nec-1.
ull rescue of NB100 cells from stenodactylin toxicity by combining
-VAD to either catalase or necrostatin-1
The viability of NB100 cells pretreated with ROS scavengers in
he absence or in the presence of Z-VAD, followed by stenodactylin
reatment was measured after 72 h (Fig. 5A). All the tested scav-
ngers were able to signiﬁcantly protect neuroblastoma cells from
tenodactylin intoxication. The scavengers CAT and NaPyr gave the
igher cell protection (52 and 55%, respectively) with respect to NAC,
rolox and BHA (ranging from 29% to 38%). When ROS scavengers
ere co-administered with Z-VAD, their protective effect was in all
ases signiﬁcantly augmented (p ≤ 0.0001). The co-administration of
AT and Z-VAD completely rescued NB100 cells from stenodactylin-
nduced cell death after 72 h (Fig. 5A).
To determine the relationship between ROS blockage and caspase
ctivation in stenodactylin-treated cells, AnnexinV positivity and cas-
ase 3/7 activation were evaluated in cells pretreated with CAT. After
2 h, double staining with AnnexinV/PI showed the typical pattern of
arly and late apoptosis in stenodactylin-treated cells (Fig. 5B). Time-
ourse experiments (24–96 h) demonstrated that caspases are acti-
ated after 24 h of incubation with stenodactylin, with a plateau ob-
erved starting from 48 h, showing approximately 300% activation
ompared with control and 50% cell viability (Fig. 5C). The maximal
alue of caspase 3/7 activation through stenodactylin in the presence
f CAT was signiﬁcantly lower (p ≤ 0.0001) than that obtained in ab-
ence of the scavenger (compare Fig. 2E and Fig. 5C). These results
onﬁrmed that the apoptotic pathway is also activated in cells pre-
reated with CAT, although after longer times and to a lesser extent.
Cell viability was also evaluated in time-course experiments af-
er combined pretreatment, Z-VAD + CAT, Z-VAD + Nec-1 or CAT +ec-1. The combination CAT + Nec-1 did not ensure a long-term pro-
ection of NB100 cells. However, the combination of the pan-caspase
nhibitor and the hydrogen peroxide scavenger and the combination
f the pan-caspase inhibitor and the necroptosis inhibitor completely
nhibited stenodactylin-induced cell death at all times, even at 96 h
Fig. 5D).
iscussion
Stenodactylin is one of the most cytotoxic type 2 plant toxins,
articularly towards nervous cells (Monti et al. 2007). Accordingly,
n the present study, stenodactylin completely abolished neuroblas-
oma protein synthesis and cell viability at an extremely low con-
entration and in a short time (1 pM, 24 h), making this toxin
n attractive candidate for the design and production of drugs for
linical application (Wiley and Lappi 2001; Bolognesi and Polito
004).
Understanding the cell death pathways elicited through a poten-
ial drug represents a milestone in preclinical studies. Considering
he results obtained at 24 h, all the evidences seemed to indicate the
poptosis as the principal/exclusivemechanism responsible of NB100
eath by stenodactylin: cellular and nuclear morphology compatible
ith an apoptotic pattern, elevated AnnexinV positivity, alteredmito-
hondrial transmembrane potential, and strong and rapid caspase ac-
ivation. Furthermore, during the same time period, the pan-caspase
nhibitor Z-VAD almost completely rescued the cells from death after
tenodactylin exposure, demonstrating that the apoptotic pathway is
he dominant and fastest death mechanism induced through sten-
dactylin. However, the lack of total protection at incubation periods
onger than 24 h indicates that the toxin activates other cell death
echanisms.
Oxidative stress has already been shown to signiﬁcantly con-
ribute to plant toxin cytotoxicity. A mutant form of abrin, lacking
-glycosylase activity, induced apoptosis through an increase in in-
racellular ROS levels (Shih et al. 2001). The depletion of cellular an-
ioxidants or increased ROS production induced apoptosis through
itochondria-dependent and mitochondria-independent pathways
Sinha et al. 2013). Treatment with antioxidant compounds conferred
igniﬁcant protection in Jurkat cells through the restoration of the
ntioxidant enzymes depleted after abrin treatment (Saxena et al.
014).
Our results show that stenodactylin induces the early formation
f superoxide anion that is almost coincident with the caspase activa-
ion, thus suggesting that ROS molecules can be important mediators
f stenodactylin-induced apoptosis.
To assess the ROS involvement in stenodactylin intoxication of
euroblastoma cells we investigated the effect of scavengers and an-
ioxidant compounds. Indeed, after 24 h, BHA, CAT, NAC, NaPyr and
rolox showed strong protective effects, sparing the cells from the in-
oxication consequences and allowing the survival of 75–100% of cell
opulation. No protection was conferred after the addition of SOD,
ossibly reﬂecting the fact that in our experimental conditions the
nzyme cannot easily reach the intracellular compartment where the
uperoxide is produced. The protective effect of scavengers decreased
ver the time. CAT was the most eﬃcient antioxidant, with 50% of
ells remaining viable after incubation for 96 h. In CAT pretreated
ells caspase activation was delayed and reached levels of about half
ompared to not pretreated cells, indicating a correlation between
ydrogen peroxide production and apoptosis.
Oxidative stress plays a signiﬁcant pathogenic role in neuron
eath, indicating that endogenous antioxidant resources are inade-
uate or easily overwhelmed in neuronal cells (Uttara et al. 2009).
he generation of ROS may be dependent on UPR resulting from in-
reased protein folding load in ER (reviewed by Farooqi et al. 2015).
PR can protect the cell by increasing the transcription of ER chaper-
nes; although persistent ER stress can lead to apoptotic cell death.
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Fig. 4. Protective effects of the inhibitors Z-VAD (apoptosis) and Nec-1 (necroptosis) in NB100 cells treated with stenodactylin. The cells were pretreated for 3 h with Z-VAD
(A) or Nec-1 (B) (100 μM), followed by treatment with 10−12 M stenodactylin for 2 h. Viability (●) and caspase 3/7 activity (columns), expressed as the percentage of control
values obtained from cultures grown in the absence of stenodactylin, were evaluated at the indicated times. The results are presented as the means ± S.D. of three independent
experiments performed in triplicate. Data were analysed by ANOVA/Bonferroni test, followed by a comparison with Dunnett’s test for caspase experiments (conﬁdence range 95%;
∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p ≤ 0.0001 versus cells treated with stenodactylin alone, in the case of cell viability, or versus untreated cells, in the case of caspase 3/7 activation).
The morphology of cells treated with stenodactylin in the presence of the inhibitors was analysed using phase contrast microscopy (600×) (C) and double staining with AnnexinV
(green)/PI (red), followed by ﬂuorescence microscopy at 48 h after treatment (600×) (D).
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Fig. 5. Protection obtained through combinations of inhibitors and scavengers. NB100 cells were incubated for 2 h with 10−12 M stenodactylin alone or preceded by a 3-h preincu-
bation with the scavengers (30 μM BHA, 10 U/ml CAT, 30 μM NAC, 1 mM NaPyr or 30 μM Trolox) (black columns) or with the scavengers + 100 μM Z-VAD (white columns). The
viability was measured after 72 h. The statistical analysis was performed using ANOVA/Bonferroni (conﬁdence range 95%; ∗∗∗∗ p ≤ 0.0001 versus cells treated with stenodactylin
with the scavenger and without Z-VAD) (A). NB100 cells were incubated with stenodactylin after pretreatment with CAT as above. Apoptosis and necrosis were evaluated through
AnnexinV/PI double staining after 72 h using ﬂuorescence microscopy (left) or light microscopy (right) (600×) (B). Caspase 3/7 activation (columns) and cell viability (●) induced
through stenodactylin after pretreatment with CAT, were evaluated at different times (24–96 h) (C). The viability of cells treated with stenodactylin alone (●) or after preincubation
with Z-VAD + CAT, (◦), Z-VAD + Nec-1 (100 μM) () or CAT + Nec-1 (♦) was reported (D). Cell viability and caspase activation results are presented as the means ± S.D. of three in-
dependent experiments performed in triplicate. Data were analysed by ANOVA/Bonferroni test, followed by a comparison with Dunnett’s test for caspase experiments (conﬁdence
range 95%; ∗∗ p < 0.01, ∗∗∗∗ p ≤ 0.0001 versus cells treated with stenodactylin alone, in the case of cell viability, or versus untreated cells, in the case of caspase 3/7 activation).
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PER is connected to mitochondria via the mitochondria-associated
ER membranes, which regulate calcium homeostasis, mitochondrial
function, autophagy and apoptosis and are implicated in neurodegen-
erative diseases (reviewed by Vance 2014).
Previous studies have implicated roles for ROS molecules also
as initiators, modulators or effectors of necroptosis (reviewed by
Vandenabeele et al. 2010). Necroptosis is initiated through tu-
mour necrosis factor receptor activation and depends on the serine-
threonine kinase receptor-interacting proteins 1 (RIPK1) and 3
(RIPK3) and other proteins. Nec-1 blocks necroptosis through the
inhibition of RIPK1 activity (Degterev et al. 2005; Vandenabeele et
al. 2010). Pretreatment of NB100 cells with Nec-1 prior to sten-
odactylin incubation preserved approximately 70% of cells after 24 h.
The caspase activationwas slower and lower in the presence of Nec-1,
demonstrating that the necroptosis blockage can also delay the apop-
totic pathway and suggesting that apoptosis and necroptosis share
some molecular mechanisms during the ﬁrst phase of the two pro-
cesses. When NB100 cells were pretreated with the necroptosis in-
hibitor Nec-1, approximately 25% of stenodactylin-intoxicated cells
remained viable after 96 h, suggesting that at this time, necroptosis
is responsible for the death in approximately one-fourth of the cell
population.
In the present study, after 24 h, death inhibitors and ROS scav-
engers were signiﬁcantly eﬃcient in protecting neuroblastoma cells
from stenodactylin cytotoxicity. However, after longer incubation
times, this protection considerably decreased. Thus, we conducted
additional experiments treating cells with two-by-two combinations
of Z-VAD, Nec-1 and CAT. The simultaneous administration of Z-VAD
+ Nec-1 completely abolished stenodactylin-induced cell death. The
total long-term protection of neuroblastoma cells was also observed
after preincubating the cells with Z-VAD + CAT, but not with Nec-1 +
CAT. These results suggested the complementary action of apoptosis
and necroptosis in neuroblastoma cells and the more rapid activation
of apoptosis compared with necroptosis.
The caspase-dependent pathway and ROS production were the
main cell death mechanisms involved in NB100 cell toxicity through
stenodactylin. However, it is not clear whether ROS production is
apoptosis dependent or whether these molecules are responsible for
apoptosis induction. There are controversial reports on the role of
caspase 3 in the formation of ROS; indeed, caspase 3 has been im-
plicated in the production of reactive species, while in other cases,
hydrogen peroxide has been reported to activate the caspase cascade
(Zhang et al. 2001). In the present study, hydrogen peroxide produc-
tion was more strongly associated with necroptosis. In the presence
of Z-VAD, the protection conferred through CAT largely overlapped
with that conferred through Nec-1, suggesting that necroptosis is re-
lated to ROS production, at least in nervous cells.
The idea that stenodactylin elicits more than one cell death path-
way and the identiﬁcation of mechanisms involved in stenodactylin-
induced cell killing would provide useful insights for the potential
application of stenodactylin in neurobiology and medicine. Indeed,
the contribution of necroptosis has been implicated in neurological
disorder, but few in vitro and animal models are available. The char-
acteristic of retrograde transport in peripheral nerves and in the cen-
tral nervous system and the ability of stenodactylin to kill neurons
through apoptosis and necroptosis could be exploited to develop a
molecular tool for new experimental models of neurodegenerative
diseases.
In conclusions, our results conﬁrm that the high stenodactylin
toxicity to nervous cells depends on multiple cell death pathways,
which involve mainly apoptosis, but also necroptosis and the produc-
tion of free radicals. Moreover, here for the ﬁrst time, a complete and
long lasting protection from the lethal effect induced by a toxic type
2 ribosome-inactivating protein has been obtained by combining the
caspase inhibitor Z-VAD, to either the hydrogen peroxide scavenger
catalase or the necroptotic inhibitor necrostatin-1.onﬂict of interest
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